Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIntegraFin Holdings Regulatory News (IHP)

Share Price Information for IntegraFin Holdings (IHP)

Share Price is delayed by 15 minutes
Get Live Data
362.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 1.00 (0.276%)
Market Cap: £1.20b
IHP Live PriceLast checked at - London Stock Exchange

Intraday IntegraFin Holdings Share Chart

Transact Pricing Change

3 Feb 2022 10:12

RNS Number : 6168A
IntegraFin Holdings plc
03 February 2022
 

LEI Number: 213800CYIZKXK9PQYE87

 

IntegraFin Holdings plc

 

Announcement of price changes for the Transact platform

 

3 February 2022

 

IntegraFin Holdings plc highlights the price changes announced today by Transact - the market leading platform providing services to UK clients and their financial advisers.

 

Alex Scott, IHP CEO, said:

 

This price change is part of the strategy we are implementing to share the benefits of our scale with our clients, and to continue to increase our funds under direction.

 

There is limited additional impact on revenue in financial year 2022 (with the price change announced in February 2021 already coming through for the full financial year 2022), and then a full year impact in financial year 2023 which we expect to be partially offset by growth in flows.

 

Jonathan Gunby, IFAL (Transact) CEO, said:

 

We are pleased to be reducing our charges again, in a measured way, to balance our desire to share the benefits of our scale economies while investing in our service delivery for advisers and clients. More than 167,000 clients will see lower charges and those portfolios valued between £200k and £300k will enjoy both reductions.

· Buy Commission exemption threshold reduces from £300k to £200k on 1 March 2022.

· Annual Commission charge reduces from 0.27% to 0.26% (for the respective charging bands) on 1 July 2022.

 

New Transact Annual Commission Charging Structure - effective from 1 July 2022

Single or consolidated Portfolios of less than £100,000

Cash & Investments

£0 - £60,000

0.50%

>£60,000 and

0.26%

 

Single or consolidated Portfolios of £100,000 and above

Cash & Investments

£0 - £600,000

0.26%

>£600,000 - £1,200,000

0.17%

>£1,200,000 - £5,000,000

0.07%

On the remainder

0.05%

 

New Transact Buy Commission Charging Structure- effective from 1 March 2022

Monthly Average Portfolio Value

Refund

Effective Rate

0%

0.05%

£200k+

100%

0.00%

 

 

 

Enquiries

 

Media

Lansons

Tony Langham

+44 (0)79 7969 2287

Maddy Morgan Williams

+44 (0)79 4736 4578

Investors

Luke Carrivick

+44 020 7608 5463

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABKNBKKBKDOBK
Date   Source Headline
17th Jun 20264:38 pmRNSHolding(s) in Company
22nd May 202610:49 amRNSDirector/PDMR Shareholding
21st May 20269:55 amRNSDirector/PDMR Shareholding
20th May 20267:00 amRNSHalf-year Financial Report
7th May 20263:35 pmRNSHolding(s) in Company
22nd Apr 20263:35 pmRNSDirector/PDMR Shareholding
21st Apr 20267:00 amRNSQ2 Trading Update
10th Apr 202610:24 amRNSHolding(s) in Company
30th Mar 202611:39 amRNSHolding(s) in Company
24th Mar 202610:49 amRNSDirector/PDMR Shareholding
16th Mar 20263:39 pmRNSHolding(s) in Company
16th Mar 20263:39 pmRNSHolding(s) in Company
27th Feb 20267:00 amRNSResult of AGM
24th Feb 20264:13 pmRNSDirector/PDMR Shareholding
23rd Feb 20269:45 amRNSHolding(s) in Company
19th Feb 202612:06 pmRNSHolding(s) in Company
12th Feb 202612:14 pmRNSDirector/PDMR Shareholding
2nd Feb 202612:39 pmRNSDirector/PDMR Shareholding
22nd Jan 20262:14 pmRNSDirector/PDMR Shareholding
13th Jan 20265:09 pmRNSDirector/PDMR Shareholding
13th Jan 20267:00 amRNS1st Quarter Results
9th Jan 202611:49 amRNSAnnual Financial Report
30th Dec 202512:49 pmRNSHolding(s) in Company
30th Dec 202512:49 pmRNSHolding(s) in Company
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
24th Dec 202511:14 amRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
19th Dec 202512:30 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
18th Dec 202512:59 pmRNSDirector/PDMR Shareholding
17th Dec 20257:00 amRNSFinal Results
25th Nov 20259:45 amRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSReplacement: Holding(s) in Company
6th Nov 20254:03 pmRNSHolding(s) in Company
3rd Nov 20253:03 pmRNSHolding(s) in Company
28th Oct 20255:17 pmRNSHolding(s) in Company
22nd Oct 20255:02 pmRNSDirector/PDMR Shareholding
14th Oct 20257:00 amRNSQ4 Trading Update
10th Oct 20251:46 pmRNSHolding(s) in Company
29th Sep 20254:40 pmRNSDirector/PDMR Shareholding
23rd Sep 202511:26 amRNSDirector/PDMR Shareholding
22nd Sep 202511:15 amRNSHolding(s) in Company
19th Sep 202512:46 pmRNSHolding(s) in Company
19th Sep 20257:00 amRNSHolding(s) in Company
5th Sep 202512:00 pmRNSChange of Registered Office
1st Sep 202512:00 pmRNSHolding(s) in Company
26th Aug 202510:35 amRNSDirector/PDMR Shareholding
11th Aug 20253:29 pmRNSHolding(s) in Company
30th Jul 20257:00 amRNSHolding(s) in Company
23rd Jul 20254:45 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.